We have helped hundreds of patients lose weight and improve their health. to source our medications, we only use top compounding pharmacies that have earned the Pharmacy Compounding Accreditation Board’s (PCAB) Seal of AccreditationThe PCAB® Seal of Accreditation is a system of quality and safety standards created by the leading experts in the compounding pharmacy industry.
Tirzepatide is a dual incretin agonist or a “twincreatin” that acts on TWO hunger hormone receptors: GIP and GLP-1. These target areas of the brain and gut that regulate appetite and satiety (sense of fullness after eating). In 2022, it was released as an anti-diabetic medication used to treat type 2 diabetes under the name Mounjaro It was recently given "Fast Track" designation by the FDA in order to speed up the development and expedite the review to approve Mounjaro for the treatment of obesity. Zepbound is approved to treat obesity and was released in 2024.
Our tirzepatide is a compounded version, not a brand name. There is currently a nationwide shortage of all of the injectable weight loss medications. Name brand tirzepatide has been in a shortage and on the FDA Shortlist since it was released in 2022. It is important to note that per the FDA "Compounded drugs pose a higher risk to patients than FDA-approved drugs because they do not undergo FDA premarket review for safety, effectiveness, or quality." Click here for more information on the FDA shortlist and compounding pharmacies.
Compounded tirzepatide treatment is a once a week subcutaneous (SQ) injection which is typically injected into the subcutaneous fat. SQ injections are VERY easy to do and usually painless! Most patients learn how to do this during the first visit.
1) Schedule your appointment
2) Labs may be required depending on your situation. Labs are drawn in office and are an additional fee.
3) One week follow up to review how to draw up and administer injection
4) Two week follow up to receive your medication and again review how to draw up and administer injection (if needed).
5) Follow-up office visit, telemed, or phone call every 4 -6 weeks
5) In-office visit every 3 months
The most common side effects include:
The more serious side effects include:
If you experience any serious side effects, contact your healthcare provider immediately or seek emergency treatment.
The medication should not be used in anyone with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2), because there is an increased risk of developing thyroid C-cell tumors. You are NOT a good candidate if you currently have or have had in the past any of the following: diabetic retinopathy, low blood sugar (hypoglycemia), poor kidney function, or pancreatitis,
There is also an increased risk of other complications including:
This is an excellent video that demonstrates step-by-step exactly how to draw up and inject medication subcutaneously. Highly recommended and the New Zealand accent makes it fun!
Sign up to hear from us and receive special offers!
Alpha Health & Wellness
Located inside A Suite Salon, 1043 S State Rd 7, Suite 127, Wellington FL, 33414
Copyright © 2022 Alpha Health & Wellness - All Rights Reserved.
Powered by GoDaddy
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies